Trade Summary

3 days ago, Waheed Nadia, serving as Chief Medical Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 14,828 shares at $8.27 per share, for a total transaction value of $122,627.56. Following this transaction, Waheed Nadia now holds 300,079 shares of OCUL.

This sale represents a 4.71% decrease in Waheed Nadia's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:01 PM ET, 2 days after the trade was made.

OCULAR THERAPEUTIX, INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.